Evidence map›Paper›PMID 35356671›Full record

ArticleChemical science2022

A novel tyrosine hyperoxidation enables selective peptide cleavage.

Shengping Zhang, Luis M De Leon Rodriguez, Freda F Li, Renjie Huang, Ivanhoe K H Leung, Paul W R Harris, Margaret A Brimble

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. A Novel Tyrosine Hyperoxidation Enables Selective Peptide Cleavage.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shengping ZhangSchool of Chemical Sciences, The University of Auckland 23 Symonds St Auckland 1010 New Zealand paul.harris@auckland.ac.nz m.brimble@auckland.ac.nz.
Luis M De Leon RodriguezSchool of Chemical Sciences, The University of Auckland 23 Symonds St Auckland 1010 New Zealand paul.harris@auckland.ac.nz m.brimble@auckland.ac.nz.ORCID https://orcid.org/0000-0001-6130-724X
Freda F LiSchool of Chemical Sciences, The University of Auckland 23 Symonds St Auckland 1010 New Zealand paul.harris@auckland.ac.nz m.brimble@auckland.ac.nz.ORCID https://orcid.org/0000-0001-7604-2870
Renjie HuangSchool of Chemical Sciences, The University of Auckland 23 Symonds St Auckland 1010 New Zealand paul.harris@auckland.ac.nz m.brimble@auckland.ac.nz.ORCID https://orcid.org/0000-0003-4050-4652
Ivanhoe K H LeungSchool of Chemical Sciences, The University of Auckland 23 Symonds St Auckland 1010 New Zealand paul.harris@auckland.ac.nz m.brimble@auckland.ac.nz.
Paul W R HarrisSchool of Chemical Sciences, The University of Auckland 23 Symonds St Auckland 1010 New Zealand paul.harris@auckland.ac.nz m.brimble@auckland.ac.nz.ORCID https://orcid.org/0000-0002-2579-4543
Margaret A BrimbleSchool of Chemical Sciences, The University of Auckland 23 Symonds St Auckland 1010 New Zealand paul.harris@auckland.ac.nz m.brimble@auckland.ac.nz.ORCID https://orcid.org/0000-0002-7086-4096
University of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel tyrosine hyperoxidation enabling selective peptide cleavage is reported. The scission of the N-terminal amide bond of tyrosine was achieved with Dess-Martin periodinane under mild conditions, generating a C-terminal peptide fragment bearing the unprecedented hyperoxidized tyrosine motif, 4,5,6,7-tetraoxo-1

Identifiers

PMID35356671
PMCPMC8890263
OpenAlexW4211098150

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.